Shujun Yang

机构：Sun Yat-sen University, Zhengzhou University, First Affiliated Hospital of Xinxiang Medical University, Henan Cancer Hospital, Eighth Affiliated Hospital of Sun Yat-sen University, Henan Medical University

发表论文 47 篇 · 总被引 1881 次 · h-index 14

代表论文

• Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial (2022 · Cancer Cell · 被引 577)
• Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02) (2021 · Journal of Clinical Oncology · 被引 360)
• A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trial (2025 · Nature Medicine · 被引 88)
• First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study (2024 · Nature Medicine · 被引 56)
• KN046, a bispecific antibody against PD-L1 and CTLA-4, plus chemotherapy as first-line treatment for metastatic NSCLC: A multicenter phase 2 trial (2024 · Cell Reports Medicine · 被引 44)
• Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trial (2022 · The Innovation · 被引 15)